Journal of Antimicrobial Chemotherapy, Vol 39, 829-831, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
CM McMullin, NM Brown, IM Brown, CR Tomson, LO White, DS Reeves and AP MacGown
Seven patients with end-stage renal disease requiring support by continuous
ambulatory peritoneal dialysis received once-daily 400 mg oral ofloxacin
for 7 days for the treatment of bacterial peritonitis. Serum and peritoneal
dialysis fluid (PDF) were collected for assay throughout the course of the
study and for 5 days thereafter. Ofloxacin, desmethyl ofloxacin and
ofloxacin-N-oxide accumulated over the course of therapy and could still be
detected in serum and PDF 5 days after the end of therapy. The mean
elimination half-life of ofloxacin in serum was 32 +/- 7 h, desmethyl
ofloxacin 45 +/- 26 h and for ofloxacin-N-oxide 44 +/- 15 h. The total mean
recovery of ofloxacin and its metabolites from the PDF was 15.4%. This
regimen results in serum and PDF concentrations likely to be effective for
the treatment of infection for at least 10 days.
JOURNAL ARTICLE
The pharmacokinetics of once-daily oral 400 mg ofloxacin in patients with peritonitis complicating continuous ambulatory peritoneal dialysis
Bristol Centre for Antimicrobial Research and Evaluation, Southmead Health Services NHS Trust and University of Bristol, Department of Medical Microbiology, UK. lesassays@UKnequasaa.win-UK.net
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
W. Van Biesen, N. Veys, R. Vanholder, and N. Lameire Peritoneal-dialysis-related peritonitis: the art of rope-dancing Nephrol. Dial. Transplant., November 1, 2002; 17(11): 1878 - 1882. [Full Text] [PDF] |
||||
